<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In our ongoing studies of the interrelationship between platelets and the vascular wall we found that an accurate estimate could be made of the clinical condition and more effective therapy prescribed when we monitored alterations in the plasma levels of <z:chebi fb="0" ids="28728">TXB2</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>For this purpose we devised a radioimmunoassay with I125-<z:chebi fb="0" ids="28728">TXB2</z:chebi>-Tyramide </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with ischemic <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disorders</z:e>, <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">cerebral apoplexy</z:e>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:e sem="disease" ids="C0040021" disease_type="Disease or Syndrome" abbrv="">Buerger's disease</z:e>, <z:e sem="disease" ids="C0039263" disease_type="Disease or Syndrome" abbrv="">Takayasu</z:e> disease etc., <z:hpo ids='HP_0000001'>all</z:hpo> had statistically high levels of <z:chebi fb="0" ids="28728">TXB2</z:chebi> as compared with healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>In particular, patients with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> and/or <z:mp ids='MP_0001914'>hemorrhage</z:mp> <z:hpo ids='HP_0000001'>all</z:hpo> revealed increases in levels of <z:chebi fb="0" ids="28728">TXB2</z:chebi> and these levels increased in parallel with a worsening of the clinical condition, and there was always a re-increase in <z:chebi fb="0" ids="28728">TXB2</z:chebi> level before a recurrence of an attack </plain></SENT>
<SENT sid="4" pm="."><plain>As plasma <z:chebi fb="0" ids="28728">TXB2</z:chebi> levels clearly reflect thrombogenic disorders, the assessment of these levels on a routine basis, enables a more accurate diagnosis, an indication of possible recurrences, and more effective chemotherapy and rehabilitation </plain></SENT>
</text></document>